California Public Employees Retirement System’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.6M | Buy |
124,583
+11,915
| +11% | +$2.08M | 0.01% | 566 |
|
|
2025
Q4 | $19.2M | Sell |
112,668
-82,139
| -42% | -$12.6M | 0.01% | 642 |
|
|
2025
Q3 | $25.7M | Sell |
194,807
-33,606
| -15% | -$4.03M | 0.02% | 555 |
|
|
2025
Q2 | $24.2M | Sell |
228,413
-42,387
| -16% | -$4.6M | 0.02% | 557 |
|
|
2025
Q1 | $33.6M | Sell |
270,800
-15,078
| -5% | -$1.97M | 0.02% | 468 |
|
|
2024
Q4 | $35.2M | Sell |
285,878
-6,530
| -2% | -$770K | 0.02% | 475 |
|
|
2024
Q3 | $32.6M | Sell |
292,408
-6,269
| -2% | -$687K | 0.02% | 505 |
|
|
2024
Q2 | $31.9M | Sell |
298,677
-11,448
| -4% | -$1.26M | 0.02% | 485 |
|
|
2024
Q1 | $37.3M | Buy |
310,125
+31,831
| +11% | +$3.9M | 0.03% | 458 |
|
|
2023
Q4 | $34.2M | Buy |
278,294
+83,065
| +43% | +$10.4M | 0.03% | 462 |
|
|
2023
Q3 | $25.3M | Buy |
195,229
+72,441
| +59% | +$9.65M | 0.02% | 518 |
|
|
2023
Q2 | $15.2M | Sell |
122,788
-8,839
| -7% | -$1.19M | 0.01% | 701 |
|
|
2023
Q1 | $19.3M | Sell |
131,627
-15,721
| -11% | -$2.33M | 0.02% | 597 |
|
|
2022
Q4 | $23.5M | Buy |
147,348
+8,615
| +6% | +$1.26M | 0.02% | 557 |
|
|
2022
Q3 | $18.5M | Buy |
138,733
+17,820
| +15% | +$2.71M | 0.02% | 618 |
|
|
2022
Q2 | $18.9M | Sell |
120,913
-6,185
| -5% | -$952K | 0.02% | 570 |
|
|
2022
Q1 | $19.8M | Sell |
127,098
-6,537
| -5% | -$949K | 0.02% | 605 |
|
|
2021
Q4 | $17M | Sell |
133,635
-4,644
| -3% | -$610K | 0.01% | 735 |
|
|
2021
Q3 | $18M | Sell |
138,279
-3,385
| -2% | -$511K | 0.01% | 707 |
|
|
2021
Q2 | $25.2M | Buy |
141,664
+5,423
| +4% | +$939K | 0.02% | 591 |
|
|
2021
Q1 | $22.4M | Sell |
136,241
-2,053
| -1% | -$338K | 0.02% | 641 |
|
|
2020
Q4 | $22.8M | Buy |
138,294
+9,657
| +8% | +$1.44M | 0.02% | 612 |
|
|
2020
Q3 | $18.3M | Buy |
128,637
+3,576
| +3% | +$443K | 0.02% | 597 |
|
|
2020
Q2 | $13.8M | Sell |
125,061
-1,711
| -1% | -$189K | 0.01% | 663 |
|
|
2020
Q1 | $12.6M | Sell |
126,772
-6,114
| -5% | -$791K | 0.02% | 605 |
|
|
2019
Q4 | $19.8M | Buy |
132,886
+14,560
| +12% | +$1.98M | 0.02% | 618 |
|
|
2019
Q3 | $15.2M | Buy |
118,326
+29,361
| +33% | +$3.94M | 0.02% | 676 |
|
|
2019
Q2 | $12.7M | Sell |
88,965
-19,532
| -18% | -$2.62M | 0.02% | 666 |
|
|
2019
Q1 | $15.5M | Sell |
108,497
-8,316
| -7% | -$1.08M | 0.02% | 621 |
|
|
2018
Q4 | $14.5M | Sell |
116,813
-6,274
| -5% | -$931K | 0.02% | 606 |
|
|
2018
Q3 | $20.7M | Sell |
123,087
-16,572
| -12% | -$2.85M | 0.03% | 583 |
|
|
2018
Q2 | $24.1M | Buy |
139,659
+6,187
| +5% | +$1.01M | 0.03% | 527 |
|
|
2018
Q1 | $20.2M | Buy |
133,472
+8,633
| +7% | +$1.27M | 0.03% | 586 |
|
|
2017
Q4 | $16.8M | Buy |
124,839
+2,638
| +2% | +$366K | 0.02% | 674 |
|
|
2017
Q3 | $17.9M | Buy |
122,201
+5,601
| +5% | +$847K | 0.03% | 607 |
|
|
2017
Q2 | $18.1M | Buy |
116,600
+4,900
| +4% | +$749K | 0.03% | 575 |
|
|
2017
Q1 | $16.2M | Sell |
111,700
-5,000
| -4% | -$651K | 0.03% | 623 |
|
|
2016
Q4 | $12.7M | Sell |
116,700
-11,500
| -9% | -$1.28M | 0.02% | 711 |
|
|
2016
Q3 | $15.6M | Sell |
128,200
-17,000
| -12% | -$2.29M | 0.03% | 628 |
|
|
2016
Q2 | $20.5M | Hold |
145,200
| – | – | 0.03% | 504 |
|
|
2016
Q1 | $19M | Sell |
145,200
-7,500
| -5% | -$934K | 0.03% | 546 |
|
|
2015
Q4 | $21.5M | Buy |
152,700
+1,200
| +0.8% | +$166K | 0.03% | 511 |
|
|
2015
Q3 | $20.1M | Sell |
151,500
-4,700
| -3% | -$809K | 0.03% | 522 |
|
|
2015
Q2 | $27.5M | Sell |
156,200
-6,755
| -4% | -$1.21M | 0.04% | 443 |
|
|
2015
Q1 | $28.4M | Hold |
162,955
| – | – | 0.04% | 475 |
|
|
2014
Q4 | $28.4M | Buy |
162,955
+5,225
| +3% | +$867K | 0.04% | 475 |
|
|
2014
Q3 | $25.3M | Sell |
157,730
-8,570
| -5% | -$1.32M | 0.04% | 511 |
|
|
2014
Q2 | $24.4M | Sell |
166,300
-70,026
| -30% | -$9.71M | 0.03% | 540 |
|
|
2014
Q1 | $30.7M | Sell |
236,326
-35,500
| -13% | -$5.34M | 0.04% | 439 |
|
|
2013
Q4 | $34.1M | Buy |
271,826
+109,900
| +68% | +$11.4M | 0.05% | 388 |
|
|
2013
Q3 | $14.9M | Buy |
161,926
+6,266
| +4% | +$505K | 0.03% | 635 |
|
|
2013
Q2 | $10.7M | Buy |
+155,660
| New | +$9.51M | 0.02% | 741 |
|
Other funds holding JAZZ
VPM
VCM
EC
California Public Employees Retirement System's JAZZ Position: Q1 2026 in Review
California Public Employees Retirement System increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, buying an estimated $2.08M and bringing the position to 124,583 shares worth $23.6M. The position accounts for 0.01% of the portfolio, ranked #566.
California Public Employees Retirement System first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.3M in Q1 2024. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- California Public Employees Retirement System held 124,583 shares of Jazz Pharmaceuticals worth $23.6M as of Q1 2026.
- California Public Employees Retirement System bought 11,915 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.08M.
- Jazz Pharmaceuticals made up 0.01% of California Public Employees Retirement System's portfolio in Q1 2026, its #566 holding.
- California Public Employees Retirement System first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- California Public Employees Retirement System's Jazz Pharmaceuticals position peaked at $37.3M in Q1 2024.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.